Journal of Cardiovascular Pharmacology

FEBRUARY 28, 2024

Atherosclerosis is an insidious and progressive inflammatory disease characterized by the formation of lipid-laden plaques within the intima of arterial walls with potentially devastating consequences. However, despite a heterogenous substrate underlying coronary thrombosis, treatment remains identical.

Plaque 40

Plaque Thrombosis Atherosclerosis Article 40

Cardiometabolic Health Congress

AUGUST 23, 2024

Explore the CMHC Lipid Management Hub Visit the CMHC Lipid Management Hub , where you’ll find a wealth of resources, including webinars, CME activities, expert interviews, on-demand event recordings, news articles, drug pipelines, and more, all organized by specialty focus and format.

Dementia 52

Dementia Cholesterol Risk Factors CME 52

Dr. Smith's ECG Blog

NOVEMBER 30, 2022

In a recent article (J Electrocardiol this year, see reference below), peak trop onin I levels in takotsubo presenting with ST Elevation were median 1.02 Note 2: This article fails to specify whether it was troponin I or T, but I contacted the institution and they used exclusively troponin I during that time period.

Plaque 52

Plaque Chest Pain Thrombosis Stenosis 52

Dr. Smith's ECG Blog

MAY 19, 2020

Nonobstructive coronary disease by coronary angiography should be differentiated between patients with normal coronary arteries and minimal luminal irregularities (less than 30% stenosis) and mild to moderate coronary atherosclerosis (30% to less than 50%). FFR can be useful. A list of conditions that can cause this is below.

Defibrillator 52

Defibrillator Circulation Plaque Cardiac Arrest 52